Article ; Online: Arterial and venous thrombosis in coronavirus 2019 disease (Covid-19): relationship with mortality.
Internal and emergency medicine
2021 Volume 16, Issue 5, Page(s) 1231–1237
Abstract: Background: Patients with coronavirus disease 2019 (Covid-19) may experience venous thrombosis ... predicted morality.: Conclusions: Covid-19 patients experience an equipollent rate of venous and arterial ... and 75 (20%) died. Thrombotic events included 41 venous thromboembolism and 34 arterial thrombosis ...
Abstract | Background: Patients with coronavirus disease 2019 (Covid-19) may experience venous thrombosis while data regarding arterial thrombosis are sparse. Methods: Prospective multicenter study in 5 hospitals including 373 patients with Covid-19-related pneumonia. Demographic data, laboratory findings including coagulation tests and comorbidities were reported. During the follow-up any arterial or venous thrombotic events and death were registered. Results: Among 373 patients, 75 (20%) had a thrombotic event and 75 (20%) died. Thrombotic events included 41 venous thromboembolism and 34 arterial thrombosis. Age, cardiovascular disease, intensive care unit treatment, white blood cells, D-dimer, albumin and troponin blood levels were associated with thrombotic events. In a multivariable regression logistic model, intensive care unit treatment (Odds Ratio [OR]: 6.0; 95% Confidence Interval [CI] 2.8-12.6; p < 0.001); coronary artery disease (OR: 2.4; 95% CI 1.4-5.0; p = 0.022); and albumin levels (OR: 0.49; 95% CI 0.28-0.87; p = 0.014) were associated with ischemic events. Age, sex, chronic obstructive pulmonary disease, diabetes, heart failure, coronary heart disease, intensive care unit treatment, in-hospital thrombotic events, D-dimer, C-reactive protein, troponin, and albumin levels were associated with mortality. A multivariable Cox regression analysis showed that in-hospital thrombotic events (hazard ratio [HR]: 2.72; 95% CI 1.59-4.65; p < 0.001), age (HR: 1.035; 95% CI 1.014-1.057; p = 0.001), and albumin (HR: 0.447; 95% CI 0.277-0.723; p = 0.001) predicted morality. Conclusions: Covid-19 patients experience an equipollent rate of venous and arterial thrombotic events, that are associated with poor survival. Early identification and appropriate treatment of Covid-19 patients at risk of thrombosis may improve prognosis. |
---|---|
MeSH term(s) | Aged ; Aged, 80 and over ; C-Reactive Protein/analysis ; COVID-19/complications ; COVID-19/epidemiology ; Coronary Artery Disease/epidemiology ; Coronary Artery Disease/etiology ; Female ; Fibrin Fibrinogen Degradation Products/analysis ; Humans ; Intensive Care Units/organization & administration ; Intensive Care Units/statistics & numerical data ; Kaplan-Meier Estimate ; Logistic Models ; Male ; Middle Aged ; Mortality/trends ; Odds Ratio ; Proportional Hazards Models ; Prospective Studies ; Thromboembolism/epidemiology ; Thromboembolism/etiology |
Chemical Substances | Fibrin Fibrinogen Degradation Products ; fibrin fragment D ; C-Reactive Protein (9007-41-4) |
Language | English |
Publishing date | 2021-07-04 |
Publishing country | Italy |
Document type | Journal Article ; Multicenter Study ; Research Support, Non-U.S. Gov't |
ZDB-ID | 2454173-4 |
ISSN | 1970-9366 ; 1828-0447 |
ISSN (online) | 1970-9366 |
ISSN | 1828-0447 |
DOI | 10.1007/s11739-020-02621-8 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
Full text online
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.A 6673: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.